nodes	percent_of_prediction	percent_of_DWPC	metapath
Proflavine—F2—endothelium—acquired immunodeficiency syndrome	0.105	0.221	CbGeAlD
Proflavine—F2—blood plasma—acquired immunodeficiency syndrome	0.0937	0.196	CbGeAlD
Proflavine—F2—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.0578	0.111	CbGpPWpGaD
Proflavine—F2—lymphoid tissue—acquired immunodeficiency syndrome	0.0365	0.0762	CbGeAlD
Proflavine—F2—digestive system—acquired immunodeficiency syndrome	0.036	0.0753	CbGeAlD
Proflavine—F2—blood—acquired immunodeficiency syndrome	0.0343	0.0717	CbGeAlD
Proflavine—F2—bone marrow—acquired immunodeficiency syndrome	0.0332	0.0694	CbGeAlD
Proflavine—F2—spinal cord—acquired immunodeficiency syndrome	0.0331	0.0691	CbGeAlD
Proflavine—F2—lung—acquired immunodeficiency syndrome	0.0301	0.0629	CbGeAlD
Proflavine—F2—nervous system—acquired immunodeficiency syndrome	0.0279	0.0582	CbGeAlD
Proflavine—F2—central nervous system—acquired immunodeficiency syndrome	0.0268	0.0561	CbGeAlD
Proflavine—F2—Syndecan-4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.0266	0.051	CbGpPWpGaD
Proflavine—F2—Syndecan-4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.0266	0.051	CbGpPWpGaD
Proflavine—F2—brain—acquired immunodeficiency syndrome	0.0213	0.0445	CbGeAlD
Proflavine—F2—Syndecan-4-mediated signaling events—CCL5—acquired immunodeficiency syndrome	0.0202	0.0388	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.0201	0.0385	CbGpPWpGaD
Proflavine—F2—IL1 and megakaryotyces in obesity—IFNG—acquired immunodeficiency syndrome	0.0149	0.0286	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.0139	0.0267	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0135	0.0259	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.0128	0.0246	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.0122	0.0234	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.011	0.0211	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.011	0.0211	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0103	0.0197	CbGpPWpGaD
Proflavine—F2—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	0.0101	0.0193	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.00953	0.0183	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.00895	0.0172	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00817	0.0157	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.00817	0.0157	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00753	0.0144	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00739	0.0142	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.00728	0.014	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00681	0.013	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.00664	0.0127	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.0064	0.0123	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.0064	0.0123	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00622	0.0119	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.0059	0.0113	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.00578	0.0111	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00563	0.0108	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.00537	0.0103	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.00529	0.0101	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.00528	0.0101	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00527	0.0101	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00505	0.00968	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00487	0.00933	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00457	0.00875	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.00439	0.00841	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.0043	0.00824	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00429	0.00823	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00429	0.00823	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.00427	0.00818	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.00425	0.00815	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00384	0.00737	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00348	0.00666	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.00347	0.00665	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.00342	0.00655	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00327	0.00627	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00327	0.00627	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00327	0.00626	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00319	0.00612	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00311	0.00597	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00294	0.00564	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00289	0.00554	CbGpPWpGaD
Proflavine—F2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.0028	0.00537	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.00277	0.00531	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.00276	0.00528	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00249	0.00477	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.00225	0.0043	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00224	0.00429	CbGpPWpGaD
Proflavine—F2—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.00219	0.0042	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00197	0.00378	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00196	0.00377	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00189	0.00362	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00189	0.00362	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00185	0.00354	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00185	0.00354	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00178	0.00342	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00171	0.00327	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00168	0.00322	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00168	0.00322	CbGpPWpGaD
Proflavine—F2—Hemostasis—ALB—acquired immunodeficiency syndrome	0.00143	0.00274	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00141	0.00269	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00138	0.00265	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00135	0.00259	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00128	0.00245	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00127	0.00243	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00126	0.00241	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00117	0.00223	CbGpPWpGaD
Proflavine—F2—Hemostasis—IL2—acquired immunodeficiency syndrome	0.00116	0.00222	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00115	0.0022	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00105	0.00202	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000991	0.0019	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000991	0.0019	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000754	0.00145	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000743	0.00142	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000731	0.0014	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000679	0.0013	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000664	0.00127	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000392	0.000752	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00039	0.000748	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000231	0.000442	CbGpPWpGaD
